ITP in the 21st Century
Open Access
- 1 January 2006
- journal article
- review article
- Published by American Society of Hematology in Hematology
- Vol. 2006 (1), 402-407
- https://doi.org/10.1182/asheducation-2006.1.402
Abstract
Immune (or idiopathic) thrombocytopenic purpura (ITP) is commonly encountered by the practicing hematologist. Clinical management decisions have traditionally been guided by individual training and past experience. Input from the literature has been more from observational reports of case series than from scientific results of hypothesis-driven research. Practice guidelines and several surveys of clinical hematology practice have highlighted important questions in the field, and in the past 5 to 10 years both clinical and laboratory investigations have produced valuable new information. Thrombopoietin levels are normal or only slightly increased in ITP, and stimulation of thrombopoiesis appears to be a promising new therapeutic approach in clinical trials. Chronic, refractory ITP in children or adults remains a challenge for the hematologist. It is this group that has the greatest risk of serious bleeding, particularly among the elderly. The anti-B–cell monoclonal antibody, anti-CD20, has shown benefit in phase I/II clinical trials in patients who had failed a number of previous therapeutic modalities. The standard for clinical research into therapy for ITP has become evidence-based medicine, and more prospective, randomized clinical trials are being completed by multi-institutional study groups.Keywords
This publication has 38 references indexed in Scilit:
- Childhood ITP: 12 months follow‐up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)Pediatric Blood & Cancer, 2005
- Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesAmerican Journal of Hematology, 2004
- Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patientsBritish Journal of Haematology, 2003
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003
- Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their ParentsJournal of Pediatric Hematology/Oncology, 2003
- Childhood Acute Immune Thrombocytopenic Purpura: 20 Years LaterSeminars in Thrombosis and Hemostasis, 2003
- Grading of hemorrhage in children with idiopathic thrombocytopenic purpuraThe Journal of Pediatrics, 2002
- Immune Thrombocytopenic PurpuraThe New England Journal of Medicine, 2002
- Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational studyThe Lancet, 2001
- Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelinesThe Lancet, 1997